Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03236194 · ClinicalTrials.gov registry record
Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT03236194: Completed study, sponsored by Milton S. Hershey Medical Center.
NCT03236194 is a clinical trial that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03236194 has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The investigators will be studying the development of the microbiome over the first year after birth in light of various environmental influences - e.g. mode of delivery, diet (and diet changes), antibiotic exposure, GERD medication exposure.
Primary Outcome
Microbiome diversity within individuals (how gut and oral microbiomes are similar or different) and between individuals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2019-01-30 |
What the finished NCT03236194 record still lists
NCT03236194 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03236194 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03236194 about?
NCT03236194 is a clinical study titled "Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life". The investigators will be studying the development of the microbiome over the first year after birth in light of various environmental influences - e.g. mode of delivery, diet (and diet changes), antibiotic exposure, GERD medication exposure.
What is the current status of trial NCT03236194?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-07-17. Estimated completion is 2019-01-30.
Who is sponsoring clinical trial NCT03236194?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI